| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 37.31B | 36.25B | 29.28B | 27.98B | 26.32B | 24.72B |
| Gross Profit | 7.95B | 7.21B | 5.83B | 5.48B | 5.31B | 4.43B |
| EBITDA | 3.59B | 3.29B | 1.95B | 1.71B | 1.68B | 749.00M |
| Net Income | 3.71B | 3.00B | 2.20B | 1.23B | 1.36B | 329.00M |
Balance Sheet | ||||||
| Total Assets | 46.02B | 48.74B | 48.86B | 41.18B | 38.14B | 38.58B |
| Cash, Cash Equivalents and Short-Term Investments | 6.07B | 4.39B | 10.06B | 7.88B | 11.13B | 7.12B |
| Total Debt | 6.40B | 5.51B | 7.29B | 3.99B | 3.99B | 5.99B |
| Total Liabilities | 18.88B | 20.13B | 21.09B | 17.13B | 14.93B | 16.78B |
| Stockholders Equity | 26.91B | 28.33B | 27.57B | 23.86B | 23.07B | 21.68B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -4.42B | -2.16B | -2.69B | 5.96B | 3.04B |
| Operating Cash Flow | 0.00 | -3.70B | -891.00M | -2.50B | 6.09B | 3.30B |
| Investing Cash Flow | 0.00 | 654.00M | 550.00M | -63.00M | 510.00M | -551.00M |
| Financing Cash Flow | 0.00 | -2.70B | 2.45B | -727.00M | -2.51B | -4.48B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥32.89B | 6.16 | ― | 2.77% | 15.61% | 81.99% | |
78 Outperform | ¥70.13B | 9.50 | ― | 2.63% | -6.00% | -13.74% | |
76 Outperform | ¥47.70B | 11.21 | ― | 3.32% | 18.47% | 64.23% | |
75 Outperform | ¥65.74B | 13.24 | ― | 3.95% | -1.67% | -4.39% | |
70 Outperform | ¥172.16B | 7.70 | 8.17% | 2.04% | 1.48% | 58.59% | |
70 Outperform | ¥87.15B | 4.09 | ― | 3.09% | 6.35% | -34.20% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |